Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
Journal of Lipid Research|January 20, 2004
APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT studyPhilippa J Talmud, Steve Martin, Marja-Riitta Taskinen, et al.
Atherosclerosis|March 17, 2004
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosisMikko Syvänne, Roslyn A Whittall, Ursula Turpeinen, et al.
Diabetes, Obesity & Metabolism|January 19, 2021
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetesJonathan M Wilson, Amir Nikooienejad, Deborah A Robins, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2006
Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thicknessHiroshi Watanabe, Sanni Söderlund, Aino Soro-Paavonen, et al.
American Journal of Human Genetics|March 14, 2002
Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish familiesAino Soro, Päivi Pajukanta, Heidi E Lilja, et al.
Diabetes Care|March 21, 2012
Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohortJames D Best, Paul L Drury, Timothy M E Davis, et al.
Heart (British Cardiac Society)|April 26, 2014
Cardiac steatosis in patients with dilated cardiomyopathyMarit Granér, Markku O Pentikäinen, Kristofer Nyman, et al.
Journal of Lipid Research|July 20, 2004
Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemiaHeidi E Lilja, Elina Suviolahti, Aino Soro-Paavonen, et al.
Diabetes Care|January 31, 2006
Serum lipids and the progression of nephropathy in type 1 diabetesMerlin C Thomas, Milla Rosengård-Bärlund, Vashti Mills, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2011
Dual metabolic defects are required to produce hypertriglyceridemia in obese subjectsMarja-Riitta Taskinen, Martin Adiels, Jukka Westerbacka, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
Journal of Lipid Research|January 20, 2004
APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT studyPhilippa J Talmud, Steve Martin, Marja-Riitta Taskinen, et al.
Atherosclerosis|March 17, 2004
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosisMikko Syvänne, Roslyn A Whittall, Ursula Turpeinen, et al.
Diabetes, Obesity & Metabolism|January 19, 2021
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetesJonathan M Wilson, Amir Nikooienejad, Deborah A Robins, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2006
Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thicknessHiroshi Watanabe, Sanni Söderlund, Aino Soro-Paavonen, et al.
American Journal of Human Genetics|March 14, 2002
Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish familiesAino Soro, Päivi Pajukanta, Heidi E Lilja, et al.
Diabetes Care|March 21, 2012
Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohortJames D Best, Paul L Drury, Timothy M E Davis, et al.
Heart (British Cardiac Society)|April 26, 2014
Cardiac steatosis in patients with dilated cardiomyopathyMarit Granér, Markku O Pentikäinen, Kristofer Nyman, et al.
Journal of Lipid Research|July 20, 2004
Locus for quantitative HDL-cholesterol on chromosome 10q in Finnish families with dyslipidemiaHeidi E Lilja, Elina Suviolahti, Aino Soro-Paavonen, et al.
Diabetes Care|January 31, 2006
Serum lipids and the progression of nephropathy in type 1 diabetesMerlin C Thomas, Milla Rosengård-Bärlund, Vashti Mills, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2011
Dual metabolic defects are required to produce hypertriglyceridemia in obese subjectsMarja-Riitta Taskinen, Martin Adiels, Jukka Westerbacka, et al.
Pageof 23